Request Trial
17 December 2025VideosEuropeCharles Larsen, McDermott Will & Emery | Marcus Dalton, Curevac | Shohta Ueno, Regeneron | Rachel Fetches, HGF | Edger Brinkman, Unified Patent Court

WATCH: Behind the scenes of big ticket litigation — lessons from the courts

High-value IP disputes are reshaping life sciences litigation, with perspectives from McDermott Will & Emery, Curevac, Regeneron, HGF, and the UPC.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Europe
Final call: Who are the world’s best in-house counsel?
16 January 2026   A first-of-its-kind project by sister title WIPR aims to highlight the world’s leading in-house intellectual property counsel—and it needs your help.
Europe
Bayer secures key Denmark ruling as Xarelto faces expiry pressure
13 January 2026   As the drug moves deeper into its post-exclusivity phase, a Nordic decision highlights the value of secondary patents, presumption of validity, and interim relief when a drug's core patents expire.
Europe
CIPA’s outgoing president: UK rejoining the UPC needs ‘support from business’
7 January 2026   As he hands over the baton, Bobby Mukherjee reflects on his time leading the Chartered Institute of Patent Attorneys—from progressing the soon-to-be-launched paid apprenticeship schemes to engaging with the UK body’s in-house members. Sarah Speight reports.


Editor's picks

Final call: Who are the world’s best in-house counsel?
Europe
Final call: Who are the world’s best in-house counsel?
16 January 2026

Editor's picks

Europe
Final call: Who are the world’s best in-house counsel?
16 January 2026
Americas
SCOTUS shuts the door on Entresto ‘after-arising technology’ review
17 December 2025
Europe
Abbott appeals ‘baffling’ decision in glucose monitoring device feud
16 December 2025
Americas
Teva scrubs 200-plus Orange Book patents after FTC turns the screw
11 December 2025
Americas
US govt backs Hikma over ‘skinny label’ rules
9 December 2025
Big Pharma
The clinical trial dilemma: Navigating European practice
27 November 2025

More features

AI is transforming top 100 innovators, shows index
Final call: Who are the world’s best in-house counsel?
Italian medtech startup beats larger US rival in UPC dispute
Goodwin targets transatlantic patent work with London hire
Bayer secures key Denmark ruling as Xarelto faces expiry pressure
Carpmaels & Ransford builds Munich UPC team with elite hire
Why the US is poised for a patent litigation surge in 2026
How AI will be shaped by legal and regulatory developments in 2026